XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Equity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Jun. 07, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Unrecognized compensation expense $ 131,000   $ 131,000    
Restricted Stock Units (RSUs) [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of restricted stock units vested 0 0 30,083 16,499  
Weighted average exercise price average intrinsic value     $ 15.63 $ 19.95  
Unrecognized compensation expense $ 347,000   $ 347,000    
Restricted Stock Units (RSUs) [Member] | Board Of Directors [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of restricted stock units granted 0 11,166 7,662 43,666  
Grant date fair value   $ 8.06 $ 11.75 $ 12.41  
Vesting period       3 years  
2023 Equity Incentive Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Shares authorized for issuance under plan         300,000
Combined 2023 Plan And 2014 Equity Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Shares available for grant 358,416   358,416    
Combined 2023 Plan And 2014 Equity Plan [Member] | 2014 Equity Incentive Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Shares available for grant 123,076   123,076